Perspective Chapter: Role of Immunosuppressive and Immunomodulatory Agents in Cancer
Immunosuppressants offer some benefits and disadvantages. Like a blade with two edges, immunosuppressants are categorized as drugs but also cause decreased immunity, which eventually cause cancer. Immunosuppressants are widely used in organ transplantation patients and autoimmune illnesses to suppre...
Guardado en:
| Autores principales: | , , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2022
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/85196 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| _version_ | 1879164798316314624 |
|---|---|
| author | Palupi, Poppy Diah Khan, Mohammed Safwan Ali Amalina, Nur Dina |
| author_browse | Amalina, Nur Dina Khan, Mohammed Safwan Ali Palupi, Poppy Diah |
| author_facet | Palupi, Poppy Diah Khan, Mohammed Safwan Ali Amalina, Nur Dina |
| author_sort | Palupi, Poppy Diah |
| building | IntechOpen |
| collection | Acceso abierto |
| description | Immunosuppressants offer some benefits and disadvantages. Like a blade with two edges, immunosuppressants are categorized as drugs but also cause decreased immunity, which eventually cause cancer. Immunosuppressants are widely used in organ transplantation patients and autoimmune illnesses to suppress the immune response and provide a significant risk of cancer. According to epidemiological and cancer research, malignancies are higher among transplant patients. However, the risk varies significantly between studies due to methods and patient selection variations. A more accurate illustration of the effects of mild-to-moderate immunosuppression concerning the risk of cancer can be seen in the rising use of immunosuppressant medications in non-transplant patients. Generally, cancer cells have an approach to avoid immune surveillance and create a complex balance in which many immune subtypes may be responsible for controlling tumor development, metastasis, and resistance. Therefore, the main objective of most cancer immunotherapies is to reestablish effective immune control. Immunomodulators help to maintain immune system function and promote the immune system’s capacity to fight and defeat cancer. One of them is immune checkpoint inhibitors. |
| doi_str_mv | 10.5772/intechopen.109072 |
| first_indexed | 2026-10-15T21:40:04Z |
| format | Book Chapter |
| fullrecord | <oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><identifier>intech-85196</identifier><datestamp>2022-12-11</datestamp>
<dc:title>Perspective Chapter: Role of Immunosuppressive and Immunomodulatory Agents in Cancer</dc:title>
<dc:creator>Poppy Diah Palupi</dc:creator>
<dc:creator>Mohammed Safwan Ali Khan</dc:creator>
<dc:creator>Nur Dina Amalina</dc:creator>
<dc:subject>Life Sciences</dc:subject>
<dc:description>Immunosuppressants offer some benefits and disadvantages. Like a blade with two edges, immunosuppressants are categorized as drugs but also cause decreased immunity, which eventually cause cancer. Immunosuppressants are widely used in organ transplantation patients and autoimmune illnesses to suppress the immune response and provide a significant risk of cancer. According to epidemiological and cancer research, malignancies are higher among transplant patients. However, the risk varies significantly between studies due to methods and patient selection variations. A more accurate illustration of the effects of mild-to-moderate immunosuppression concerning the risk of cancer can be seen in the rising use of immunosuppressant medications in non-transplant patients. Generally, cancer cells have an approach to avoid immune surveillance and create a complex balance in which many immune subtypes may be responsible for controlling tumor development, metastasis, and resistance. Therefore, the main objective of most cancer immunotherapies is to reestablish effective immune control. Immunomodulators help to maintain immune system function and promote the immune system’s capacity to fight and defeat cancer. One of them is immune checkpoint inhibitors.</dc:description>
<dc:publisher>IntechOpen</dc:publisher>
<dc:date>2022-12-11</dc:date>
<dc:type>Chapter, Part Of Book</dc:type>
<dc:identifier>https://www.intechopen.com/chapters/85196</dc:identifier>
<dc:identifier>doi:10.5772/intechopen.109072</dc:identifier>
<dc:language>en</dc:language>
<dc:relation>ISBN:978-1-83768-071-9</dc:relation>
<dc:rights>https://creativecommons.org/licenses/by/3.0/</dc:rights>
<dc:source>https://www.intechopen.com/books/11848 ; Immunosuppression and Immunomodulation</dc:source>
</oai_dc:dc> |
| id | intech-85196 |
| institution | IntechOpen |
| isbn | 978-1-83768-071-9 |
| language | English |
| last_indexed | 2026-10-15T21:40:04Z |
| publishDate | 2022 |
| publishDateRange | 2022 |
| publishDateSort | 2022 |
| publisher | IntechOpen |
| publisherStr | IntechOpen |
| record_format | oai_dc |
| spelling | intech-851962022-12-11 Perspective Chapter: Role of Immunosuppressive and Immunomodulatory Agents in Cancer Poppy Diah Palupi Mohammed Safwan Ali Khan Nur Dina Amalina Life Sciences Immunosuppressants offer some benefits and disadvantages. Like a blade with two edges, immunosuppressants are categorized as drugs but also cause decreased immunity, which eventually cause cancer. Immunosuppressants are widely used in organ transplantation patients and autoimmune illnesses to suppress the immune response and provide a significant risk of cancer. According to epidemiological and cancer research, malignancies are higher among transplant patients. However, the risk varies significantly between studies due to methods and patient selection variations. A more accurate illustration of the effects of mild-to-moderate immunosuppression concerning the risk of cancer can be seen in the rising use of immunosuppressant medications in non-transplant patients. Generally, cancer cells have an approach to avoid immune surveillance and create a complex balance in which many immune subtypes may be responsible for controlling tumor development, metastasis, and resistance. Therefore, the main objective of most cancer immunotherapies is to reestablish effective immune control. Immunomodulators help to maintain immune system function and promote the immune system’s capacity to fight and defeat cancer. One of them is immune checkpoint inhibitors. IntechOpen 2022-12-11 Chapter, Part Of Book https://www.intechopen.com/chapters/85196 doi:10.5772/intechopen.109072 en ISBN:978-1-83768-071-9 https://creativecommons.org/licenses/by/3.0/ https://www.intechopen.com/books/11848 ; Immunosuppression and Immunomodulation |
| spellingShingle | Life Sciences Palupi, Poppy Diah Khan, Mohammed Safwan Ali Amalina, Nur Dina Perspective Chapter: Role of Immunosuppressive and Immunomodulatory Agents in Cancer |
| title | Perspective Chapter: Role of Immunosuppressive and Immunomodulatory Agents in Cancer |
| title_full | Perspective Chapter: Role of Immunosuppressive and Immunomodulatory Agents in Cancer |
| title_fullStr | Perspective Chapter: Role of Immunosuppressive and Immunomodulatory Agents in Cancer |
| title_full_unstemmed | Perspective Chapter: Role of Immunosuppressive and Immunomodulatory Agents in Cancer |
| title_short | Perspective Chapter: Role of Immunosuppressive and Immunomodulatory Agents in Cancer |
| title_sort | perspective chapter role of immunosuppressive and immunomodulatory agents in cancer |
| topic | Life Sciences |
| url | https://www.intechopen.com/chapters/85196 |
| work_keys_str_mv | AT palupipoppydiah perspectivechapterroleofimmunosuppressiveandimmunomodulatoryagentsincancer AT khanmohammedsafwanali perspectivechapterroleofimmunosuppressiveandimmunomodulatoryagentsincancer AT amalinanurdina perspectivechapterroleofimmunosuppressiveandimmunomodulatoryagentsincancer |